{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:03Z","timestamp":1787010183084,"version":"build-2736575974"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/mjt.0b013e3181ff7a8b","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T12:28:41Z","timestamp":1293798521000},"page":"121-132","source":"Crossref","is-referenced-by-count":29,"title":["Management of Refractory Ascites"],"prefix":"10.1097","volume":"19","author":[{"given":"Shashideep","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K.","family":"Baikati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim I.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sury","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors.","volume":"7","author":"Gines","year":"1987","journal-title":"Hepatology"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2007-1007196","article-title":"Pathogenesis of ascites in cirrhosis.","volume":"17","author":"Gines","year":"1997","journal-title":"Semin Liver Disord"},{"key":"R3-11-20210202","first-page":"645","article-title":"Pathogenesis of ascites in cirrhosis.","volume":"78","author":"Arroyo","year":"1987","journal-title":"Minerva Med"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gut.24.8.761","article-title":"Aldosterone related blood volume expansion in cirrhosis before and after the early phase of ascites formation.","volume":"24","author":"Bernardi","year":"1983","journal-title":"Gut"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International ascites Club.","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites.","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0676.1993.tb00624.x","article-title":"Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content.","volume":"13","author":"Bernardi","year":"1993","journal-title":"Liver"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/hep.1840140205","article-title":"A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.","volume":"14","author":"Gatta","year":"1991","journal-title":"Hepatology"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites.","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1089-3261(05)70193-8","article-title":"The pathophysiologic basis for the treatment of cirrhotic ascites.","volume":"5","author":"Wong","year":"2001","journal-title":"Clin Liver Dis"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7326\/0003-4819-94-2-198","article-title":"Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.","volume":"94","author":"Arroyo","year":"1981","journal-title":"Ann Intern Med"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.20066","article-title":"Management of adult patients with ascites due to cirrhosis.","volume":"39","author":"Runyon","year":"2004","journal-title":"Hepatology"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2008-1040320","article-title":"The management of ascites and hyponatremia in cirrhosis.","volume":"28","author":"Gines","year":"2008","journal-title":"Semin Liver Disord"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3748\/wjg.15.67","article-title":"Evaluation and management of patients with refractory ascites.","volume":"15","author":"Senousy","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1089-3261(05)70118-5","article-title":"Mechanisms of ascites formation.","volume":"4","author":"Cardenas","year":"2000","journal-title":"Clin Liver Disord"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-1007294","article-title":"Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis.","volume":"14","author":"Schrier","year":"1994","journal-title":"Semin Liver Disord"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","article-title":"Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.","volume":"38","author":"Arroyo","year":"2003","journal-title":"J Hepatol"},{"key":"R27-11-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1034\/j.1600-0676.2001.021003161.x","article-title":"Nitric oxide and the liver.","volume":"21","author":"Farzaneh-Far","year":"2001","journal-title":"Liver"},{"key":"R28-11-20210202","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0168-8278(02)00319-7","article-title":"Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis.","volume":"38","author":"Helmy","year":"2003","journal-title":"J Hepatol"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S1542-3565(05)00861-X","article-title":"Management of refractory ascites.","volume":"3","author":"Cardenas","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-11-20210202","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0016-5085(86)90249-0","article-title":"Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.","volume":"90","author":"Pokros","year":"1986","journal-title":"Gastroenterology"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(86)90912-5","article-title":"Renal function abnormalities, prostaglandins, and effects of non-steroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis.","volume":"81","author":"Arroyo","year":"1986","journal-title":"Am J Med"},{"key":"R35-11-20210202","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/hep.510240620","article-title":"The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis.","volume":"24","author":"Pirlich","year":"1996","journal-title":"Hepatology"},{"key":"R36-11-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"key":"R37-11-20210202","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0002-9343(87)90156-2","article-title":"Unpredictability of clinical evaluation of renal function in cirrhosis.","volume":"82","author":"Papadakis","year":"1987","journal-title":"Am J Med"},{"key":"R38-11-20210202","first-page":"212","article-title":"Urinary sodiumpotassium ratio on random sample as a useful tool to assess diuretic-induced natriuresis on chronic liver disease-associated ascitis.","volume":"102","author":"Pinto-Marques","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R39-11-20210202","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jhep.2001.20646","article-title":"Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.","volume":"33","author":"Spahr","year":"2001","journal-title":"Hepatology"},{"key":"R40-11-20210202","first-page":"324","article-title":"The significance of urine sodium measurement after furosemide administration in diuretics unresponsive patients with liver cirrhosis.","volume":"9","author":"Cho","year":"2003","journal-title":"Taehan Kan Hakhoe Chi"},{"key":"R41-11-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.510250111","article-title":"Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients.","volume":"25","author":"Kravetz","year":"1997","journal-title":"Hepatology"},{"key":"R42-11-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.510270104","article-title":"Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients.","volume":"27","author":"Nevens","year":"1998","journal-title":"Hepatology"},{"key":"R43-11-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM199402033300508","article-title":"Care of patients with ascites.","volume":"330","author":"Runyon","year":"1994","journal-title":"N Engl J Med"},{"key":"R44-11-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/hep.1840140205","article-title":"A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.","volume":"14","author":"Gatta","year":"1991","journal-title":"Hepatology"},{"key":"R45-11-20210202","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites.","volume":"350","author":"Gines","year":"2004","journal-title":"N Engl J Med"},{"key":"R46-11-20210202","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"R48-11-20210202","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1440-1746.2007.05081.x","article-title":"Spontaneous bacterial peritonitis and bacterascites prevalence in symptomatic cirrhotic outpatients undergoing large volume paracentesis.","volume":"23","author":"Castellote","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R49-11-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl Med"},{"key":"R50-11-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.2006.113050","article-title":"Restricted use of albumin for spontaneous bacterial peritonitis.","volume":"56","author":"Sigal","year":"2007","journal-title":"Gut"},{"key":"R52-11-20210202","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"R53-11-20210202","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2005.02387.x","article-title":"Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.","volume":"21","author":"Pache","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R54-11-20210202","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2001.03781.x","article-title":"Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.","volume":"96","author":"Hu","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"vi","key":"R55-11-20210202","first-page":"1","article-title":"Guidelines on the management of ascites in cirrhosis.","volume":"55","author":"Moore","year":"2006","journal-title":"Gut"},{"key":"R56-11-20210202","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.","volume":"325","author":"Gines","year":"1991","journal-title":"N Engl J Med"},{"key":"R57-11-20210202","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0016-5085(89)91430-3","article-title":"Effect of dieresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement.","volume":"97","author":"Runyon","year":"1989","journal-title":"Gastroenterology"},{"key":"R58-11-20210202","first-page":"179","article-title":"Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases.","volume":"51","author":"Pozzi","year":"2005","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R59-11-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","article-title":"Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.","volume":"28","author":"Appenrodt","year":"2008","journal-title":"Liver Int"},{"key":"R61-11-20210202","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"R62-11-20210202","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"R63-11-20210202","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"R64-11-20210202","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.1840140613","article-title":"Large-volume paracentesis and intravenous saline: effects on the renin-angiotensin system.","volume":"14","author":"Cabrera","year":"1991","journal-title":"Hepatology"},{"key":"R65-11-20210202","first-page":"1930","article-title":"The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascitesa randomized multicentric study.","volume":"54","author":"Lata","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"R66-11-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"R67-11-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/gut.51.5.755","article-title":"Terlipressin and arterial blood volume after paracentesis for tense ascites in cirrhosis.","volume":"51","author":"Singh Ranger","year":"2002","journal-title":"Gut"},{"key":"R68-11-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","article-title":"Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.","volume":"21","author":"Singh","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R69-11-20210202","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","article-title":"Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.","volume":"103","author":"Singh","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R70-11-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2796.2006.01654.x","article-title":"Noradrenaline and albumin in paracentesis induced circulatory dysfunction in cirrhosis: a randomized pilot study.","volume":"260","author":"Singh","year":"2006","journal-title":"J Intern Med"},{"key":"R71-11-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1148\/radiology.162.2.3797662","article-title":"Experimental intrahepatic portacaval anastomosis: use of expandable Gianturco stents.","volume":"162","author":"Rosch","year":"1987","journal-title":"Radiology"},{"key":"R72-11-20210202","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"},{"key":"R73-11-20210202","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000658-197910000-00012","article-title":"Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts.","volume":"190","author":"Reichle","year":"1979","journal-title":"Ann Surg"},{"key":"R74-11-20210202","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","article-title":"The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.","volume":"332","author":"Ochs","year":"1995","journal-title":"N Engl J Med"},{"key":"R75-11-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0002-9343(99)00029-7","article-title":"Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.","volume":"106","author":"Wong","year":"1999","journal-title":"Am J Med"},{"key":"R76-11-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.","volume":"25","author":"Lebrec","year":"1996","journal-title":"J Hepatol"},{"key":"R77-11-20210202","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.","volume":"342","author":"Rossle","year":"2000","journal-title":"N Engl J Med"},{"key":"R78-11-20210202","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Salvatori F. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"R79-11-20210202","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"R80-11-20210202","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites.","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"R81-11-20210202","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0016-5085(03)00377-9","article-title":"Transjugular intrahepatic portosystemic shunt: current status.","volume":"124","author":"Boyer","year":"2003","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R83-11-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000171579","article-title":"Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy.","volume":"14","author":"Rossle","year":"1996","journal-title":"Dig Dis"},{"key":"R84-11-20210202","first-page":"549","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.","volume":"90","author":"Somberg","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"R85-11-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.510230105","article-title":"The hematologic consequences of transjugular intrahepatic portosystemic shunts.","volume":"23","author":"Sanyal","year":"1996","journal-title":"Hepatology"},{"key":"R86-11-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hep.510230123","article-title":"Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome.","volume":"23","author":"Conn","year":"1996","journal-title":"Hepatology"},{"key":"R87-11-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: randomized trial.","volume":"25","author":"Lebrec","year":"1996","journal-title":"J Hepatol"},{"key":"R88-11-20210202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-8278(01)00309-9","article-title":"MELD score is better than Child-Pugh score in predicting 3-month survival in patients undergoing transjugular intrahepatic portosystemic shunt.","volume":"36","author":"Salerno","year":"2002","journal-title":"J Hepatol"},{"key":"R89-11-20210202","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Runyon. Management of adult patients with ascites due to cirrhosis: an update.","volume":"49","author":"Bruce","year":"2009","journal-title":"Hepatology"},{"key":"R90-11-20210202","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM198912143212403","article-title":"Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.","volume":"321","author":"Stanley","year":"1989","journal-title":"N Engl J Med"},{"key":"R91-11-20210202","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9610(01)00565-7","article-title":"Management of medically refractory ascites.","volume":"181","author":"Zervos","year":"2001","journal-title":"Am J Surg"},{"key":"R92-11-20210202","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1051-0443(98)70440-3","article-title":"Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study.","volume":"9","author":"Rozenblit","year":"1998","journal-title":"J Vasc Interv Radiol"},{"key":"R93-11-20210202","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites.","volume":"350","author":"Gines","year":"2004","journal-title":"N Engl J Med"},{"key":"R94-11-20210202","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.","volume":"11","author":"Ruf","year":"2005","journal-title":"Liver Transpl"},{"key":"R95-11-20210202","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD.","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"R96-11-20210202","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/lt.21197","article-title":"An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.","volume":"13","author":"Luca","year":"2007","journal-title":"Liver Transpl"},{"key":"R97-11-20210202","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"key":"R98-11-20210202","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.","volume":"46","author":"Krag","year":"2007","journal-title":"Hepatology"},{"key":"R99-11-20210202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/00365520510024043","article-title":"Octreotide in the treatment of refractory ascites of cirrhosis.","volume":"41","author":"Kalambokis","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"R100-11-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2006.09.012","article-title":"Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.","volume":"46","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"key":"R101-11-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007296","article-title":"Hepatorenal disorders: role of the sympathetic nervous system.","volume":"14","author":"Henriksen","year":"1994","journal-title":"Semin Liver Dis"},{"key":"R102-11-20210202","first-page":"1","article-title":"Interest of the association clonidine-spironolactone in cirrhotic patients with ascites and activation of sympathetic nervous system.","volume":"65","author":"Lenaerts","year":"2002","journal-title":"Acta Gastroenterol Belg"},{"key":"R103-11-20210202","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hep.21355","article-title":"Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.","volume":"44","author":"Lenaerts","year":"2006","journal-title":"Hepatology"},{"key":"R104-11-20210202","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0399-8320(05)82178-5","article-title":"Comparative pilot study of repeated large volume paracentesis vs the combination of clonidine-spironolactone in the treatment of cirrhosis-associated refractory ascites.","volume":"29","author":"Lenaerts","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"R105-11-20210202","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial.","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-201203000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:41:58Z","timestamp":1618022518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201203000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181ff7a8b","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}